443P Phase III trial of afatinib vs erlotinib in patients (pts) with squamous cell carcinoma (SCC) of the lung (LUX-Lung 8): EGFR molecular aberrations and survival outcomes
| Autor: | Park, K., Li, W., Zhou, C., Felip, E., Cobo, M., Goss, G.D., Soria, J.-C., Syrigos, K., Krämer, N., Chand, V.K., Solca, F., Lu, S. |
|---|---|
| Zdroj: | In Annals of Oncology 1 December 2015 26 Supplement 9:ix125-ix125 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|